Helen Burt, PhD
Helen Burt joined the Faculty of Pharmaceutical Sciences in 1980 and is the Angiotech Professor of Drug Delivery, and Associate VP Research at UBC. Dr. Burt has developed numerous drug delivery technologies with over 30 applications in 8 patent families (several licensed to pharmaceutical companies) and over 140 peer-reviewed publications. She has received the NSERC Synergy Award for Innovation, CSPS Award of Leadership in Canadian Pharmaceutical Sciences, and YWCA Woman of Distinction Award for Science, Research and Technology. Dr. Burt is a founding scientist in the Centre for Drug Research and Development (CDRD), a member of the Canadian Academy of Health Sciences and has served on the Board of Directors of the Provincial Health Services Authority. Dr. Burt’s laboratory was instrumental in the initial application of the core polymer technology as a drug-delivery platform, and is actively working on mechanism-of-action studies for STK-01 in collaboration with the CDRD.

  • 2011-present: Associate Vice President, Research, UBC
  • 2004: Co-founder of the Centre for Drug Research and Development (CDRD)
  • 2004-present: Angiotech Professor of Drug Delivery, UBC
  • 1980-present: Faculty member, Faculty of Pharmaceutical Sciences, UBC
  • 1980: PhD, Pharmaceutics, University of British Columbia
  • 1975: BSc Pharm, University of Bath, England

Martin Gleave, MD
Martin Gleave is is a clinician-scientist and urologic surgeon, and is the Executive Director of the Vancouver Prostate Centre at Vancouver General Hospital/UBC, is CEO of PC-TRiADD, a Center of Excellence in Commercialization of Research, and was a founder of OncoGenex Pharmaceuticals Inc. Dr. Gleave practices at the Vancouver Prostate Centre and also conducts clinical trials in urology. He provides both clinical and scientific oversight for the development of the platform toward additional applications.

  • 2009: Launched PC-TRiADD CECR
  • 2005: BC Leadership Chair in Prostate Cancer
  • 2003: Distinguished Professor, UBC Faculty of Medicine
  • 2001: Founded OncoGenex Pharmaceuticals, Inc. (CSO until 2010)
  • 1998: Fellow of the American College of Surgeons
  • 1993: Director, Vancouver Prostate Centre
  • 1992: Urologic Oncology Fellowship, University of Texas MD Anderson
  • 1989: Fellow at the Royal College of Surgeons of Canada
  • 1984: MD, University of British Columbia

Don Brooks, PhD
Don Brooks joined the faculty of UBC in 1974 and is Professor in Chemistry and in Pathology and Laboratory Medicine, in addition to an appointment at the Centre for Blood Research.  He is the past-Associate VP Research for UBC.  He has published over 150 research scientific papers, has edited four books and holds four US patents, two of which form the scientific basis for and are licensed by a successful point-of-care diagnostic company in Vancouver. He received the 2002 Golden Jubilee Medal, the 2000 UBC Alumni Award for Research, and has received recognition from NASA and the American Chemical Society for his research.

  • 2006-2011: Associate VP Research & International, UBC
  • 1974-present: Professor, UBC Faculty of Medicine
  • 1974-present: Professor, UBC Faculty of Science (Chemistry)
  • Board Member, PROOF Centre of Excellence
  • Fellow of the Canadian Academy of Health Sciences
  • Faculty Member, Green College
  • 1971-1974: Postdoctoral Fellowships at Cambridge and Weizmann Institute
  • 1971: PhD Biochemistry, University of Oregon
  • 1967: MSc Physics, University of British Columbia

Jayachandran Kizhakkedathu, PhD
Dr. Kizhakkedathu’s expertise combines advanced polymer chemistry with tailored biological analysis. His research career has been spent on matching the molecular level interactions of synthetic polymers with biological systems, to design novel biomaterials in a translational setting. Since joining the Department of Pathology and Laboratory Medicine, and the Centre for Blood Research (CBR) at the University of British Columbia, Dr. Kizhakkedathu has developed an interdisciplinary research program on the application of synthetic polymers. He take an integrative, interdisciplinary approach with an understanding of the pathophysiology of diseases in combination with well-designed biological assays and animal models towards the discovery of novel polymers as therapeutics. His research has been published in leading journals including Nature Biotechnology, Nature Materials, Science Translational Medicine, Nature Communications, Biomaterials and Journal of the American Chemical Society. Dr. Kizhakkedathu is an Associate Professor, Department of Pathology and Laboratory Medicine at the University of British Columbia. Dr. Kizhakkedathu is involved in the development of a scalable manufacturing process.

  • Associate Professor, Pathology and Laboratory Medicine, Medicine, UBC
  • Associate Member, Department of Chemistry, UBC
  • 2013: UBC Faculty of Medicine ‘Distinguished Achievement Award’
  • 2011: Michael Smith Foundation for Health Research Career Scholar
  • 2011: Department of Pathology and Laboratory Medicine ‘Excellence in Research and Discovery Award’
  • 2005: CIHR New Investigator